![An implantable shock absorber yields an 85% survival-from-arthroplasty rate through 5 years in working-age patients with medial compartment knee osteoarthritis | Knee Surgery, Sports Traumatology, Arthroscopy An implantable shock absorber yields an 85% survival-from-arthroplasty rate through 5 years in working-age patients with medial compartment knee osteoarthritis | Knee Surgery, Sports Traumatology, Arthroscopy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00167-023-07373-4/MediaObjects/167_2023_7373_Fig1_HTML.jpg)
An implantable shock absorber yields an 85% survival-from-arthroplasty rate through 5 years in working-age patients with medial compartment knee osteoarthritis | Knee Surgery, Sports Traumatology, Arthroscopy
![Moximed Raises $40 Million to Advance World's First Implantable Shock Absorber for Knee Osteoarthritis - Ortho Spine News Moximed Raises $40 Million to Advance World's First Implantable Shock Absorber for Knee Osteoarthritis - Ortho Spine News](https://orthospinenews.com/wp-content/uploads/2022/08/Moximed1a.jpg)
Moximed Raises $40 Million to Advance World's First Implantable Shock Absorber for Knee Osteoarthritis - Ortho Spine News
![MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moxim – MED-TAC International Corp. MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moxim – MED-TAC International Corp.](https://www.medgadget.com/wp-content/uploads/2023/07/Moximed_MISHA.png)
MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moxim – MED-TAC International Corp.
![Clinical trial shows implantable device reduces knee pain, increases functionality for 90% of osteoarthritis patients – Ohio State University Wexner Medical Center Clinical trial shows implantable device reduces knee pain, increases functionality for 90% of osteoarthritis patients – Ohio State University Wexner Medical Center](https://msnewsroommedia.s3.amazonaws.com/mcp/osuwmc/2022/kneeimplantupdate/03-Images/01-Photos/05-chuck.jpg)